Max Robotics — Global Service Robot Directory + US Certification

About

Richard Hindley is a leading urological surgeon whose research focuses on advancing minimally invasive treatments for renal and prostate cancers. His work has been instrumental in redefining surgical standards, particularly through comparative studies of robot-assisted and ablative techniques. Hindley’s landmark 2013 paper on robot-assisted partial nephrectomy versus laparoscopic cryoablation for small renal masses (37 citations) challenged existing paradigms by demonstrating superior oncologic outcomes and reduced morbidity for the robotic approach, helping establish it as a new “gold standard” in nephron-sparing surgery. His ongoing impact is evident in the RAFT trial (2021, 20 citations), which prospectively evaluated robotic surgery after focal therapy for prostate cancer, providing critical safety and toxicity data that guide treatment sequencing in recurrent disease. More recently, his 2024 matched-pair analysis of robot-assisted radical prostatectomy in men with prior trans-urethral resection of the prostate (2 citations) addresses a challenging clinical scenario, offering evidence for surgical feasibility and outcomes. Hindley’s contributions have shaped urologic oncology practice by rigorously comparing emerging technologies and expanding the evidence base for robotic surgery, making him a respected voice in the field.